Wells Fargo
IGC icon

Wells Fargo’s IGC Pharma IGC Stock Holding History

Wells Fargo’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-379
Closed -$152 – 7151
2024
Q1 		$152 Buy
379
+6
+2% +$2 ﹤0.01% 6564
2023
Q4 		$104 Buy
373
+74
+25% +$23 ﹤0.01% 6759
2023
Q3 		$107 Sell
299
-57
-16% -$20 ﹤0.01% 6756
2023
Q2 		$111 Buy
356
+15
+4% +$5 ﹤0.01% 6845
2023
Q1 		$116 Buy
341
+5
+1% +$2 ﹤0.01% 6904
2022
Q4 		$107 Buy
336
+12
+4% +$5 ﹤0.01% 6776
2022
Q3 		$0 Buy
324
+27
+9% +$14 ﹤0.01% 6960
2022
Q2 		$0 Buy
297
+24
+9% +$15 ﹤0.01% 7100
2022
Q1 		$0 Buy
273
+1
+0.4% +$1 ﹤0.01% 7397
2021
Q4 		$0 Buy
272
+7
+3% +$9 ﹤0.01% 7489
2021
Q3 		$0 Sell
265
-3,971
-94% -$6.42K ﹤0.01% 7216
2021
Q2 		$7K Buy
4,236
+3,998
+1,680% +$6.1K ﹤0.01% 6237
2021
Q1 		$0 Buy
238
+20
+9% +$36 ﹤0.01% 7095
2020
Q4 		$0 Sell
218
-987
-82% -$1.46K ﹤0.01% 6716
2020
Q3 		$1K Buy
1,205
+976
+426% +$992 ﹤0.01% 6209
2020
Q2 		$0 Buy
229
+2
+0.9% +$1 ﹤0.01% 6524
2020
Q1 		$0 Buy
+227
New +$126 ﹤0.01% 6468
2019
Q2 		– Sell
-200
Closed – – 6479
2019
Q1 		$0 Buy
+200
New +$455 ﹤0.01% 6233
2014
Q3 		– Sell
-293,442
Closed -$417K – 6242
2014
Q2 		$417K Hold
293,442
– – ﹤0.01% 4008
2014
Q1 		$229K Hold
293,442
– – ﹤0.01% 4273
2013
Q4 		$305K Hold
293,442
– – ﹤0.01% 4049
2013
Q3 		$308K Hold
293,442
– – ﹤0.01% 3990
2013
Q2 		$470K Buy
+293,442
New +$615K ﹤0.01% 3719

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Wells Fargo's IGC Position: Q2 2024 in Review

Wells Fargo sold out of IGC Pharma (IGC) in Q2 2024, closing a stake of 379 shares — an estimated $152 sold.

Wells Fargo first reported a position in IGC in Q2 2013 and held it in 23 quarters. The position peaked at $470K in Q2 2013. 25 funds tracked by Wall St. Rank hold IGC as of Q2 2024.

  • Wells Fargo reported no remaining IGC Pharma position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 379 IGC Pharma shares in Q2 2024, an estimated $152.
  • Wells Fargo first reported a position in IGC Pharma in Q2 2013 and held it in 23 quarters.
  • Wells Fargo's IGC Pharma position peaked at $470K in Q2 2013.
  • 25 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.